🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Watch our Research Manager, Gunes Sevinc, outline strategies to standardize the implementation of Goal Attainment Scaling as a personalized endpoint in clinical development. #webinars #PFDD #Goalattainmentscaling #personalizedendpoints Watch full webinar:buff.ly/3GuShow

Our collaboration with the DEE-P Connections and FamilieSCN2A sought to describe what meaningful change means in individuals affected by severe SCN2A-related developmental and epileptic encephalopathy. #DEEs #raredisease #Goalattainmentscaling buff.ly/3tp5tYY

Warm wishes from our company to all our valued partners and dedicated employees! May this holiday season bring joy and warmth to your hearts. Here's to a joyful celebration and a prosperous new year in 2024! #Holidays #Newyear #2024

In our recent collaboration with the InchStone project, we explored clinical trial readiness in rare DEEs through the lens of patient-focused drug development guidelines and #personalizedendpoints. Read the full publication here: neurology.org/doi/10.1212/WN… #PFDD #Raredisease #GAS

#Throwback to one example evaluating the utility of #GoalAttainmentScaling (GAS) as an outcome measure in Alzheimer's disease. We explored GAS’s sensitivity to change, allowing it to detect small but menaingfulchanges. #personalizedendpoints #COAs buff.ly/3SEjEll

We're gearing up for World Orphan Drug Congress USA in April. Our #abstracts have been submitted, and we’re preparing our workshop with TREND Community on personalized endpoints in #PraderWilli Syndrome. Join us in Boston! #patientcenteredoutcomes #sociallistening #raredisease #partnership

#InternationalWomensDay! Today we celebrate all women contributing to scientific research and impacting lives. As a women-led company, we're proud to have Chere Chapman at the helm and a 60% female workforce. #IWD2024 #inclusion #womeninstem bit.ly/41AsZyw

Excited to see this cutting-edge research from our Co-Founder & President Kenneth Rockwood, Claudia, and colleagues at UCL outlining the novel use of #GAS to support independent living in #Alzheimer's disease in the UK. #personalizedendpoints buff.ly/49FX1EF

🚨 New release of #WhatsWithRWE! We spoke with Chere Chapman, CEO of Ardea Outcomes, a Canadian CRO focusing on goal attainment scaling (GAS) in #clinicaltrials. Watch the short video below (5 min) as Chere dives into the genesis of the organization. youtu.be/TxZqjDB8lHU

New #Publication Alert🚨 📝 We conducted a systematic review of studies that implemented #GoalAttainmentScaling (GAS) with caregiver input and examined variations in the implementation, analysis, and reporting of GAS in these studies. Access here: buff.ly/4cIBhtP

We look forward to #ISPORAnnual in Atlanta, GA. Join us for our poster presentation! Our team will present a review of Goal Attainment Scaling (GAS) implementation as a personalized clinical outcome assessment over the Last Decade. #conferences #ISPOR #goalattainmentscaling

Heading to #ISPORannual? Join us on May 6th for our poster presentation and meet our CEO, Chere Chapman! We would love to discuss everything #GoalAttainmentScaling (GAS)and how it can be utilized as a personalized endpoint. #ISPOR #Clinicaltrials #GoalAttainmentScale #endpoints

Last April, we launched our first Ardea Outcomes Monthly Edit. Our newsletter features the most recent #GoalAttainmentScaling (GAS) scientific updates and team news. Make sure to sign up for our GAS newsletter to get the latest news! buff.ly/3wUjcsv #newsletters

🚀 We’re excited to see the EU-US ctad Task Force highlight #GoalAttainmentScaling as a novel, personalized outcome measure in their recent publication! Thanks to the authors for advancing innovative approaches to #Alzheimer's research. 🧠📊 Read more: buff.ly/45zQie3

Excited about the new #publication on #GoalAttainmentScaling (GAS) in #dementia care, co-authored by Dr. Kenneth Rockwood, Claudia, highlighting the NIDUS Family intervention's positive impact on achieving personalized goals. buff.ly/4cGvsg0 #NIDUSFamily #Dementia

The “cutting-edge” approach of #GoalAttainmentScaling has the power to give the patient a voice in decision-making and to deliver truly patient-centred #ClinicalTrials, says Chere Chapman, co-founder and CEO at Ardea Outcomes. Read more here: rarerevolutionmagazine.com/goal-attainmen…

#ISOQOL Don't miss our upcoming workshop tomorrow in partnership with IQVIA at Salon 17 Darmstadt from 1:00–4:00 PM. Get to learn more about #GoalAttainmentScaling. Looking forward to seeing you there!

#ISPOR Europe! We are excited to connect with peers and industry leaders and engage in insightful discussions about #GoalAttainmentScaling (GAS) and clinical outcomes. Don't miss our podium presentation on Monday, the 18th, at 2:30 PM. #ISPOR #ISPOREU #Clinicaloucomes #endpoints

We are excited and ready for #ISPOREurope! Stop by our booth #527 to chat with our team and CEO about #GoalAttainmentScaling and learn how we can assist your organization in implementing this #personalizedendpoint in #clinicaldevelopment. We look forward to seeing you there!